On the other hand, KLK-mediated degradation of extracellular matrix proteins facilitates tumor cell invasion and metastasis [59], and higher serum levels of other kallikreins such as KLK5 [60], KLK10 [61], and KLK14 [62] have been found in women with breast cancer when compared to healthy ones. This evidence concerns the gene KLK10 and breast carcinoma.